mirador® xtra
adama - suspensioonikontsentraat - asoksüstrobiin + tsüprokonasool - fungitsiidid
opdualag
bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanoom - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.
bcg-medac intravesikaalsuspensiooni pulber ja lahusti
medac gesellschaft für klinische spezialpräparate mbh - bcg bakterid - intravesikaalsuspensiooni pulber ja lahusti - 1tk
tomahawk® 200 ec
adama - emulsioonikontsentraat - fluroksüpüür - herbitsiidid
moxisolv la süstelahus
bimeda animal health limited - moksidektiin - süstelahus - 100mg 1ml 50ml 1tk
firmagon
ferring pharmaceuticals a/s - degareliks - eesnäärmevähk - endokriinset ravi - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
vancomycin pharmaswiss infusioonilahuse pulber
pharmaswiss ceska republika s.r.o. - vankomütsiin - infusioonilahuse pulber - 1000mg 1tk; 1000mg 10tk
santiola süstelahus
krka d.d. novo mesto - klosanteel - süstelahus - 50mg 1ml 250ml 4tk; 50mg 1ml 250ml 1tk